Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 419

1.

Severe mental illness at ART initiation is associated with worse retention in care among HIV-infected Ugandan adults.

Nachega JB, Mutamba B, Basangwa D, Nguyen H, Dowdy DW, Mills EJ, Katabira E, Nakimuli-Mpungu E.

Trop Med Int Health. 2013 Jan;18(1):53-7. doi: 10.1111/tmi.12019. Epub 2012 Nov 8.

2.
4.

Retention and risk factors for attrition among adults in antiretroviral treatment programmes in Tanzania, Uganda and Zambia.

Koole O, Tsui S, Wabwire-Mangen F, Kwesigabo G, Menten J, Mulenga M, Auld A, Agolory S, Mukadi YD, Colebunders R, Bangsberg DR, van Praag E, Torpey K, Williams S, Kaplan J, Zee A, Denison J.

Trop Med Int Health. 2014 Dec;19(12):1397-410. doi: 10.1111/tmi.12386. Epub 2014 Sep 17.

5.

Factors associated with attrition, mortality, and loss to follow up after antiretroviral therapy initiation: data from an HIV cohort study in India.

Alvarez-Uria G, Naik PK, Pakam R, Midde M.

Glob Health Action. 2013 Sep 12;6:21682. doi: 10.3402/gha.v6i0.21682.

6.

Quantifying retention during pre-antiretroviral treatment in a large urban clinic in Uganda.

Castelnuovo B, Musaazi J, Musomba R, Ratanshi RP, Kiragga AN.

BMC Infect Dis. 2015 Jul 1;15:252. doi: 10.1186/s12879-015-0957-1.

7.

Patient retention, clinical outcomes and attrition-associated factors of HIV-infected patients enrolled in Zimbabwe's National Antiretroviral Therapy Programme, 2007-2010.

Mutasa-Apollo T, Shiraishi RW, Takarinda KC, Dzangare J, Mugurungi O, Murungu J, Abdul-Quader A, Woodfill CJ.

PLoS One. 2014 Jan 29;9(1):e86305. doi: 10.1371/journal.pone.0086305. eCollection 2014.

8.

Risk of tuberculosis after antiretroviral treatment initiation: a comparison between efavirenz and nevirapine using inverse probability weighting.

Hermans SM, Manabe YC, Kiragga AN, Hoepelman AI, Lange JM, van Leth F.

Antivir Ther. 2013;18(4):615-22. doi: 10.3851/IMP2525. Epub 2013 Feb 19.

PMID:
23423604
9.

Incident tuberculosis during antiretroviral therapy contributes to suboptimal immune reconstitution in a large urban HIV clinic in sub-Saharan Africa.

Hermans SM, Kiragga AN, Schaefer P, Kambugu A, Hoepelman AI, Manabe YC.

PLoS One. 2010 May 7;5(5):e10527. doi: 10.1371/journal.pone.0010527.

10.
11.

Community adherence support improves programme retention in children on antiretroviral treatment: a multicentre cohort study in South Africa.

Grimwood A, Fatti G, Mothibi E, Malahlela M, Shea J, Eley B.

J Int AIDS Soc. 2012 May 31;15(2):17381. doi: 10.7448/IAS.15.2.17381.

12.

The effect of complete integration of HIV and TB services on time to initiation of antiretroviral therapy: a before-after study.

Kerschberger B, Hilderbrand K, Boulle AM, Coetzee D, Goemaere E, De Azevedo V, Van Cutsem G.

PLoS One. 2012;7(10):e46988. doi: 10.1371/journal.pone.0046988. Epub 2012 Oct 5.

13.

Treatment outcomes among HIV-1 and HIV-2 infected children initiating antiretroviral therapy in a concentrated low prevalence setting in West Africa.

Okomo U, Togun T, Oko F, Peterson K, Townend J, Peterson I, Jaye A.

BMC Pediatr. 2012 Jul 8;12:95. doi: 10.1186/1471-2431-12-95.

14.

Characteristics and outcomes of adult Ethiopian patients enrolled in HIV care and treatment: a multi-clinic observational study.

Melaku Z, Lamb MR, Wang C, Lulseged S, Gadisa T, Ahmed S, Habtamu Z, Alemu H, Assefa T, Abrams EJ.

BMC Public Health. 2015 May 3;15:462. doi: 10.1186/s12889-015-1776-4.

15.

Could early antiretroviral therapy entail more risks than benefits in sub-Saharan African HIV-infected adults? A model-based analysis.

Anglaret X, Scott CA, Walensky RP, Ouattara E, Losina E, Moh R, Becker JE, Uhler L, Danel C, Messou E, Eholié S, Freedberg KA.

Antivir Ther. 2013;18(1):45-55. doi: 10.3851/IMP2231. Epub 2012 Jul 18.

16.

Factors associated with late antiretroviral therapy initiation among adults in Mozambique.

Lahuerta M, Lima J, Nuwagaba-Biribonwoha H, Okamura M, Alvim MF, Fernandes R, Assan A, Hoos D, Elul B, El-Sadr WM, Nash D.

PLoS One. 2012;7(5):e37125. doi: 10.1371/journal.pone.0037125. Epub 2012 May 15.

17.

Treatment response and mortality among patients starting antiretroviral therapy with and without Kaposi sarcoma: a cohort study.

Maskew M, Fox MP, van Cutsem G, Chu K, Macphail P, Boulle A, Egger M, Africa FI.

PLoS One. 2013 Jun 5;8(6):e64392. doi: 10.1371/journal.pone.0064392. Print 2013.

18.

Initiation of antiretroviral therapy in HIV-infected tuberculosis patients in rural Kenya: an observational study.

Stockdale AJ, Nkuranga J, Török ME, Faragher B, Lalloo DG.

Trop Med Int Health. 2013 Jul;18(7):907-14. doi: 10.1111/tmi.12110. Epub 2013 Apr 17.

19.

Factors Associated with Timing of Initiation of Antiretroviral Therapy among HIV-1 Infected Adults in the Niger Delta Region of Nigeria.

Ogoina D, Finomo F, Harry T, Inatimi O, Ebuenyi I, Tariladei WW, Afolayan AA.

PLoS One. 2015 May 1;10(5):e0125665. doi: 10.1371/journal.pone.0125665. eCollection 2015.

20.

Low retention of HIV-infected patients on antiretroviral therapy in 11 clinical centres in West Africa.

Ekouevi DK, Balestre E, Ba-Gomis FO, Eholie SP, Maiga M, Amani-Bosse C, Minga A, Messou E, Sow PS, Lewden C, Traoré HA, Bissagnene E, Dabis F; IeDEA West Africa Collaboration.

Trop Med Int Health. 2010 Jun;15 Suppl 1:34-42. doi: 10.1111/j.1365-3156.2010.02505.x.

Items per page

Supplemental Content

Write to the Help Desk